A compound with potential as a treatment for ALS has gained further promise in a new study that showed it improved the condition of mice whose motor neurons had been damaged by an environmental toxin ...

Researchers at the Maine Medical Center Research Institute (MMCRI) in Scarborough, Maine, announce their discovery that the renarrowing of arteries following balloon angioplasty can be halted by ...

A team of researchers from Nanjing University has introduced an innovative approach to cuproptosis therapy by depleting copper levels in tumor cells, challenging the current paradigm that focuses on ...

Researchers have isolated two novel bis-β-triketone hybrids, Corymbinols A (1) and B (2a/2b), from the fruits of Corymbia citriodora. Corymbinol A demonstrated a 31% inhibition of cuproptosis in HepG2 ...

A copper-based agent complex kills cancer cells in a novel way. It receives its activation signal through light. It could help where existing chemotherapy treatments reach their limits. Cuproptosis ...

Rolling submission of New Drug Application to the FDA for CUTX-101 on track to begin in the first quarter of 2021 and to be completed by the end of the second quarter of 2021 NEW YORK, Dec. 15, 2020 ...